Sedana Medical AB (publ) (STO:SEDANA)
Sweden · Delayed Price · Currency is SEK 9.55
+0.25 (2.69%)
Nov 4, 2026, 5:29 PM CET
Sedana Medical AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 198.44 | 200.23 | 178.75 | 153.87 | 122.87 | 159.15 |
Revenue Growth | 0.42% | 12.01% | 16.17% | 25.23% | -22.80% | 12.26% |
Gross Profit Gross Profit Growth | 142.03 | 142.71 | 126.14 | 108.98 | 86.07 | 106.71 |
Operating Income Operating Income Growth | -35.81 | -32.55 | -50.78 | -66.55 | -103.93 | -61.2 |
Net Income Net Income Growth | -34.54 | -59.24 | -10.67 | -59.61 | -73.51 | -57.97 |
Earnings Per Share EPS Growth | -0.36 | -0.60 | -0.11 | -0.60 | -0.74 | -0.62 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Germany Germany Growth | 96.87 | 110.05 | 110.46 | 105.62 | 86.1 | 108.7 |
Unallocated Unallocated Growth | 50.44 | 39.05 | 32.51 | 26.9 | 36.42 | - |
Sweden Sweden Growth | - | 0.37 | 0.4 | 0.71 | 0.35 | 0.61 |
Spain Spain Growth | - | 50.76 | 35.38 | 20.64 | - | - |
Total Total Growth | 198.44 | 200.23 | 178.76 | 153.87 | 122.87 | 159.15 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 39.72 | 90.98 | 193.96 | 381.8 | 607.74 | 836.18 |
Total Debt Total Debt Growth | 6.27 | 4.7 | 5.92 | 4.31 | 8.74 | 8.87 |
Net Cash (Debt) Net Cash Growth | 33.46 | 86.28 | 188.04 | 377.5 | 599 | 827.31 |
Net Cash Growth | -68.99% | -54.12% | -50.19% | -36.98% | -27.60% | 124.89% |
Net Cash Per Share Net Cash Per Share Growth | 0.34 | 0.87 | 1.89 | 3.80 | 6.03 | 8.90 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -13.2 | -12.78 | -11.77 | -38.06 | -115.43 | -41.22 |
Capital Expenditures CapEx Growth | -2.73 | -2.4 | -2.22 | -0.52 | -0.74 | -5.19 |
Free Cash Flow Free Cash Flow Growth | -15.93 | -15.18 | -13.99 | -38.58 | -116.17 | -46.41 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.57% | 71.27% | 70.57% | 70.83% | 70.06% | 67.05% |
Operating Margin | -18.04% | -16.26% | -28.41% | -43.25% | -84.59% | -38.45% |
Pretax Margin | -16.14% | -28.60% | -5.57% | -38.36% | -59.36% | -36.05% |
Profit Margin | -17.40% | -29.59% | -5.97% | -38.74% | -59.83% | -36.42% |
FCF Margin | -8.03% | -7.58% | -7.82% | -25.07% | -94.55% | -29.16% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 4.78 | 5.10 | 10.60 | 14.95 | 15.12 | 61.20 |